← Russell 3000 cross-section

EVH Evolent Health, Inc.

Trailing twelve months to 2026-06-30 · as filed 2026-08-06, not restated
Industrials

Scale

Market cap
$543m
Revenue TTM
$2.1bn
Net income TTM
$-505m
Free cash flow
Composite score
Sector rank
#2366

Valuation

P / E
EV / EBITDA
EV / sales
0.7
FCF yield
Earnings yield vs 10-yr
-97.69pp

Earnings yield vs 10-yr compares what the business earns per pound invested against the 4.73% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.

Quality and growth

Net margin
-24.1%
EBITDA margin
-15.1%
ROE
-131.8%
ROIC
-34.6%
Revenue growth
-4.5%

Insider activity, last 90 days

Net open-market
$-0.33m
Buyers
0
Sellers
1

Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.

What management said

See Note 9 for further discussion regarding our convertible notes and Credit Agreements. Revenue Recognition Our revenue contracts are typically multi-year arrangements with customers to provide solutions designed to lower the medical expenses of our partners and include our total cost of care management and specialty care management services solutions, provide comprehensive health plan operations and claims processing services, and also include transition or run-out services to customers. …Evolent Health, Inc., 10-Q, period ended 2026-06-30, filed 2026-08-06

Read the full passage →